explore -WSS

explore

author：knowledge 2025-09-29 06:11:49 - browse：722

A sign of The Cigna Group in front of trees with orange and green leaves — insurance overage from STAT — Joe Buglewicz/Bloomberg

Cigna and Humana are in discussions to merge, a potential move that would create a health insurance and prescription drug benefits titan with approximately $300 billion of annual revenue.

A proposed transaction would almost certainly prompt a close review from antitrust enforcers at the Department of Justice and the Federal Trade Commission. A merged Cigna-Humana would further consolidate the market for pharmacy benefit managers. PBMs are companies that serve as the controversial middlemen of drug pricing negotiations, and of the four largest, two are owned by Cigna and Humana.

The Wall Street Journal first reported the talks between Cigna and Humana on Wednesday, citing sources close to the situation. Wendell Potter, a health insurance whistleblower who used to work at Cigna, also wrote about merger discussions between Cigna and Humana on his blog Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Roche’s Alnylam deal shows drug firms interested in heart drugs

WSS

Why patients can’t get everything they want on drug pricing

Rep. Raul Ruiz on the physician shortage and more

Senate panel puts off hardest PBM reforms for another day

Roche’s Alnylam deal shows drug firms interested in heart drugs

Truvian presents data for its desktop blood

Mayo Clinic plans $5B tech

hotspot

explore

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Apple is now the first public company to be valued at $3 trillion

Organ aging and disease risk measured by new blood test

Virginia high school admissions case could be legal follow

The EPA's new lead rule: How one expert crunched the numbers

Apple is now the first public company to be valued at $3 trillion

Pediatric cancer treatments threatened by a new FDA policy

As demand for Covid shots wanes, Moderna seeks its next success

The haunting brain science of long Covid

Wikipedia

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

New lawsuit accuses health insurer Cigna of denying claims in bulk

Dems pitch expanding Medicare power to negotiate drug prices

Will the market for weight loss drugs really reach $100 billion?

UHS says company favors patients whose insurance pays more

Will the FTC rein in IQVIA's health data empire?

entertainment

leisure time

leisure time

hotspot